The mechanism by which fibrogenic particulates induce inflammation that can progress to lung fibrosis is uncertain. The alveolar macrophage (AM) has been implicated in the inflammatory process because of its function and reported release of inflammatory mediators when isolated from fibrotic patients. It has been recently shown that fibrogenic, but not nonfibrogenic, particulates are highly potent in inducing apoptosis of human AM. In this study, we tested the hypothesis that fibrogenic particulates could shift the phenotypic ratio of human AM to a more inflammatory condition. The macrophage phenotypes were characterized by flow cytometry targeting the RFD1 and RFD7 epitopes. Results demonstrated that chrysotile and crocidolite asbestos, as well as crystalline silica, but not titanium dioxide or wollastonite, increased the RFD1 + phenotype (inducer or immune activator macrophages) and decreased the RFD1 +RFD7+ phenotype (suppressor macrophages). These results provide a mechanistic explanation that may link apoptosis (namely, suppressor macrophages) to a shift in the ratio of macrophage phenotypes that could initiate lung inflammation.
Introduction
Inhalation of fibrogenic particulates such as asbestos and silica results in the development of lung inflammation that can progress to lung fibrosis (1) . Although these particulates have long been known to cause lung fibrosis, there is as yet no comprehensive understanding of the molecular and cellular events that lead to fibrosis. Much work in this area has focused on the alveolar macrophage (AM). The rationale behind this is 2-fold. First, AM would be expected to be among the first cells to encounter asbestos and silica as they This paper is based on a presentation at The Sixth International Meeting on the Toxicology of Natural and Man-Made Fibrous and Non-Fibrous Particles held [15] [16] [17] [18] September 1996 in Lake Placid, New York.Manuscript received at EHP26 March 1997; accepted 2 July 1997. This work was supported by National Institutes of are the first line of lung defense against microbes and are responsible for phagocytosis of inhaled foreign material (2) . Second, AM taken from fibrotic patients release a variety of proinflammatory mediators capable ofstimulating fibroblast proliferation and collagen synthesis, which are hallmarks of fibrosis (3) . For example, a previous study has shown that even in the absence of clinical evidence of lung fibrosis, subjects exposed heavily to asbestos for a number of years had AM that were much more active in releasing inflammatory mediators than matched subjects with lower asbestos exposures (4) . Therefore , macrophage activation appears to be consistent with the development of inflammation and fibrosis.
To study the mechanism(s) of macrophage activation by fibrogenic particulates, a number of laboratories, including our own, have attempted to replicate human AM activation by these particulates. Although there is some increased release of inflammatory cytokines in response to silica and asbestos, the release is orders of magnitude less than that observed using macrophages taken from fibrotic patients (4) . This suggests that some other factor or process may be involved with particulate activation of macrophages.
Several studies have demonstrated the presence of distinct macrophage phenotypes within the AM pool obtained by bronchoalveolar lavage from human subjects. The macrophage phenotypes have been described on the basis of expression of RFD1 and RFD7 epitopes found on human AM (5, 6) . RFD1 corresponds to a 28-to 33-kDa protein within the MHCII complex while RFD7 corresponds to a 77-kDa protein found intracellularly and on the cell surface (6) . Using these markers, Poulter and colleagues have classified RFD1+ AM as those strongly stimulating T lymphocytes in allogenic-mixed lymphocyte reactions, dendriticlike, nonadherent to glass, weakly phagocytic, and containing low amounts of intracellular fluorescent material (7) (8) (9) . RFD7+ AM are mature phagocytic cells (9) , and RFD1+7+ AM function as suppressor cells (7, 9) . Both RFD7+ and RFD1+ AM have significant amounts of intracellular fluorescent material, suggesting phagocytic activity. RFD1+7+ cells are very poor stimulators of allogenic mixed lymphocyte reactions and were reported to actively repress the T-cell stimulatory capacity of RFD1+ AM (7, 9) . Furthermore, addition of RFD1 monoclonal antibodies (MoAb) inhibits RFD1+ AM-mediated T-cell stimulatory activity (10) . Studies of these AM phenotypes in patients with various inflammatory diseases strongly suggest that shifts in phenotypes could play a role in disease progression (7, 11) , and regulation of these phenotypes could be important in altering disease progression and/or outcome. Therefore, if fibrogenic particulates cause a shift in these populations to a higher ratio of RFD1+ to RFD1+7+ cells, we propose that it could explain in vitro and in vivo findings that a shift in phenotype is required prior to a net change in AM activity. An increase in RFD1+ cells would increase T-cell activation, resulting in interferon-y release and development of the inflammatory cascade.
A potential mechanism for change in macrophage phenotype may be apoptosis of the suppressor population. The ability of fibrogenic particulates, but not of nonfibrogenic particulates, to cause human AM apoptosis has been described recently (12, 13) . Apoptosis was evident at concentrations of particulates well below those causing any evidence of other forms of cell injury and below doses causing human AM release of inflammatory cytokines (4 bleomycin, was reported to be a potent inducer of apoptosis in human AM (14) . Whether this defines a pattern remains to be determined. Nevertheless, apoptosis of suppressor macrophages provides a mechanism that could cause a relative increase in the effector to suppressor macrophage ratio.
The present study was designed to test the hypothesis that fibrogenic particulates such as asbestos and silica could affect the phenotype ratio of human AM in vitro. Human AM were incubated with chrysotile (CHR), crocidolite (CRO), crystalline silica (SIL), wollastonite (WOL), and titanium dioxide (TIO), then examined by flow cytometry for changes in expression of RFD1 and RFD7 surface markers.
Materials and Methods

C Cultures
Human AM were obtained by bronchoalveolar lavage of normal, nonsmoking adult volunteers of either gender as previously described (15) . Instillations of 240 to 300 ml sterile saline resulted in recoveries of 200 to 260 ml of lavage fluid that was kept at 40C until cells were isolated from the lavage fluid by centrifugation. The saline supernatant was aspirated and discarded, and the cell pellet was resuspended in a small volume (1) (2) (3) (4) (5) (17) . However, those analyses were performed using immunohistochemical staining in which both surface and intracellular markers are stained. It has been reported that RFD 1 is primarily surface and RFD7 is intracellular and surface (5 Figure 2 phenotypes RFD1+, RFD1+7+, respectively. In each case the re malized against cells incubated particulates. As a group, the flt ticulates caused a significant RFD1+ cells that persisted for significant decrease in RFD1 hr that became more evident significant decrease in the RFI also observed with the fibrog lates at 4 and 24 hr. These rel strate that fibrogenic particu shifts in the macrophage pher nonfibrogenic particulates hwith the exception ofWOL, wI to cause a short-term increase ble-positive cell phenotype tha normal by 24 hr.
Discussion
The capability of a number of genic particulates (chrysotile and crystalline silica) but not r particulates to cause apoptos AM has been recently descril Another potent but unrelated fibrogenic agent, bleomycin, also induces apoptosis of human AM (14) . This correlation between apoptosis of human AM and development of fibrosis suggests that apoptosis could be an early event in the development of lung inflammation. However, apoptosis usually does not result in the development of inflammation, especially since programmed cell death is required for normal development (18) . Therefore, the potential association between human AM 7+ apoptosis and development of an inflammatory condition required further clarification. The results from the present study may types in normal provide that association. Ice expression of The lung is constantly exposed to a cytometry as wide variety of foreign substances that
The data repre-impinge on the epithelial surface of the 's.
respiratory tract. Therefore, in order to prevent constant sensitization to these nonsingle-stained pathogenic substances and antigens, a nonspecific immune suppression mechanism must exist. This suppression of the lung man mucosa can be explained in part by the DtlYPs presence of a relatively high fraction t fibrogenic (40-50%) of RFD1+7+ AM, which downmacrophage regulate the immune response in the lung irmal human while providing nonspecific host defense rticulates (75 (8) . The lung also contains a low fraction ER, and 133 (5-10%) of an immune active phenotype, ,enic particu-characterized as being RFD1+ (17) . 4g/ml WOL) Observations consistent with the role of I phenotypes these two cell populations are increases in metry. The the RFDI+/RFDI+7+ ratio reported in 2a-c for AM lung inflammatory conditions such as and RFD7+, asthma and sacroidosis (11, 17, 19, 20) .
sults are nor-Therefore, the ability of xenobiotic agents without any to cause a shift in macrophage phenotypes brogenic par-should correlate with their ability to induce t increase in lung inflammation. 24 hr and a
The results from the present study indi-7+ cells by 4 cate that fibrogenic, but not nonfibrogenic by 24 hr. A particulates, increase the RFDI+/RFDI+7+ D7+ cells was ratio consistent with that observed in ;enic particu-human lung inflammatory conditions. sults demon-Because there was an increase in RFD1+ Llates caused and a decrease in RFD1+7+ cells, the net notypes. The change in the ratio was approximately ad no effect, 4-fold. Furthermore, the lack of effect of hich appeared nonfibrogenic particulates suggests that the e in the dou-changes observed with the fibrogenic par-.t returned to ticulates was not due to a particulateinduced artifact affecting flow cytometry. Therefore, there was an excellent correlation between the fibrogenic potency and a several fibro-shift in macrophage phenotype to a more , crocidolite inflammatory ratio consistent with the ionfibrogenic disease etiology. sis of human
The effects of the fibrogenic particubed (12, 13) . lates were progressive with time, especially (11, 17, 19, 20) , it remains to be determined whether the same also holds for lung fibrosis. Nevertheless, it appears from this study that fibrogenic particulates can cause a rapid shift in phenotypes and could precede inflammation, i.e., the shift in phenotypes is a primary rather than a secondary event. The results also indicated that fibrogenic particulates decreased the RFD7+ phenotype. Whether the presence of the RFD7 epitope could be important in apoptosis by fibrogenic particulates remains to be determined. In summary, these results provide a mechanistic explanation to link a number of findings. The results indicate that fibrogenic particulates cause a shift in macrophage phenotypes to a more inflammatory condition without having to induce inflammation by themselves. This is consistent with the general lack of any significant release of inflammatory mediators from human AM incubated with particulates in vitro. Therefore, the altered macrophage phenotype ratio, in combination with other immune cells, would generate an inflammatory condition, which explains the highly active macrophages obtained from fibrotic patients. These findings indicate that new approaches to therapy need to be explored, with agents that could restore the normal phenotype balance and ablate the progressive inflammatory condition in fibrosis.
